PET provider CTI Molecular Imaging reported fiscal fourth-quarter revenues of $86.5 million, up 15% from the $75.5 million in sales posted in the same period last year. For the quarter (end-September 30), the Knoxville, TN-based firm had net income of $7.6 million, compared with net income of $653,000 in the third quarter of 2001.
For the fiscal year (end-September 30), CTI reported revenues of $258.4 million, as compared with $188.9 million reported for the same period in 2001, an increase of 37%. Net income on a pro forma basis, after excluding the effect of nonrecurring expenses, was $16.4 million, compared with $10.4 million for the same period last year, an increase of 58%.
The vendor reported a net loss of $3.4 million, after $12.3 million in noncash stock compensation expense and $8.9 million in nonrecurring warrant mark-to-market expense for the fiscal year, as compared with net income of $6.1 million for the 2001 fiscal year. All warrants were exercised on March 31, 2002, thus, there were no noncash charges relating to warrants during the fourth quarter of 2002.
By AuntMinnie.com staff writersNovember 20, 2002
Related Reading
Brophy joins CTI as vice president and counsel, November 6, 2002
P.E.T.Net and UCLA sign molecular imaging pact, November 4, 2002
P.E.T.Net, Nelson join to market PET, September 26, 2002
CTI revenues climb 81%, August 8, 2002
CTI, DVI form financing alliance, August 6, 2002
Copyright © 2002 AuntMinnie.com
